|
Factor V Leiden detected through thrombosis of central artery of the retina.
Rev Clin Esp. 2005 Sep; 205(9):464-5.
Rubio Barbon S, Dos Santos Bernardo VM, Escalada Rodriguez P, Suarez Del Villar Acebal R |
|
New approaches and future prospects for evaluating genetic risk of thrombosis.
Haematologica. 2005 Sep; 90(9):1212-22.
Soria JM, Fontcuberta J. |
|
Obesity as a risk factor in venous thromboembolism.
Am J Med. 2005 Sep; 118(9):978-80.
Stein PD, Beemath A, Olson RE. |
|
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis.
J Thromb Haemost. 2005 Sep; 3(9):1993-7.
de Groot PG, Lutters B, Derksen RH, Lisman T, Meijers JC, Rosendaal FR. |
|
Identifying novel genetic determinants of hemostatic balance.
J Thromb Haemost. 2005 Ago; 3(8):1561-8.
Ginsburg D. |
|
Thrombophilia and pregnancy outcomes.
J Thromb Haemost. 2005 Ago; 3(8):1603-10.
Pabinger I, Vormittag R |
|
Mechanisms of homocysteine-induced atherothrombosis.
J Thromb Haemost. 2005 Ago; 3(8):1646-54.
Lentz SR |
|
Receptors, rafts, and microvesicles in thrombosis and inflammation.
J Thromb Haemost. 2005 Ago; 3(8):1737-44.
Lopez JA, del Conde I, Shrimpton CN. |
|
Activated protein C levels in Behcet´s disease and risk of venous thrombosis.
Br J Haematol. 2005 Ago; 126(4):550-6.
Navarro S, Ricart JM, Medina P, Vaya A, Villa P, Todoli J, Estelles A, Mico ML, Aznar J, Espana F. |
|
PAI-1 and atherothrombosis.
J Thromb Haemost. 2005 Ago; 3(8):1879-83.
Vaughan DE. |
|
Protease-activated receptors in hemostasis, thrombosis and vascular biology.
J Thromb Haemost. 2005 Ago; 3(8):1800-14.
Coughlin SR. |
|
Pathophysiology of the antiphospholipid syndrome.
J Thromb Haemost. 2005 Ago; 3(8):1854-60.
de Groot PG, Derksen RH |
|
Does obesity constitute a risk factor for upper-extremity deep vein thrombosis?
Thromb Haemost. 2005 Jul; 94(1):228-30.
Vaya A, Mira Y, Ferrando F, Corella D, Aznar J. |
|
Venous thrombosis in inflammatory bowel disease
Eur J Gastroenterol Hepatol. 2005 Jul; 17(7):697-700.
Srirajaskanthan R, Winter M, Muller AF |
|
Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.
Thromb Haemost. 2005 Jul; 94(1):101-6.
Arsene S, Delahousse B, Regina S, Le Lez ML, Pisella PJ, Gruel Y. |
|
Thrombophilia, clinical factors, and recurrent venous thrombotic events.
JAMA. 2005 May; 293(19):2352-61.
Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. |
|
A model-based algorithm for the monitoring of long-term anticoagulation therapy.
J Thromb Haemost. 2005 May; 3(5):915-21.
Pasterkamp E, Kruithof CJ, VAN DERMeer FJ, Rosendaal FR, Vanderschoot JP. |
|
The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
J Thromb Haemost. 2005 May; 3(5):1102-3.
Vossen CY, Rosendaal FR. |
|
Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers
J Thromb Haemost. 2005 May; 3(5):922-8.
Reynolds TC, Butine MD, Visich JE, Gunewardena KA, MacMahon M, Pederson S, Bishop PD, Morton KM |
|
Type 2 diabetes: an atherothrombotic syndrome
Curr Mol Med. 2005 May; 5(3):323-32.
Dunn EJ, Grant PJ |
